195 related articles for article (PubMed ID: 31601683)
1. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase.
Lazo JS; Blanco IK; Tasker NR; Rastelli EJ; Burnett JC; Garrott SR; Hart DJ; McCloud RL; Hsu KL; Wipf P; Sharlow ER
J Pharmacol Exp Ther; 2019 Dec; 371(3):652-662. PubMed ID: 31601683
[TBL] [Abstract][Full Text] [Related]
2. Structure of the Complex of an Iminopyridinedione Protein Tyrosine Phosphatase 4A3 Phosphatase Inhibitor with Human Serum Albumin.
Czub MP; Boulton AM; Rastelli EJ; Tasker NR; Maskrey TS; Blanco IK; McQueeney KE; Bushweller JH; Minor W; Wipf P; Sharlow ER; Lazo JS
Mol Pharmacol; 2020 Dec; 98(6):648-657. PubMed ID: 32978326
[TBL] [Abstract][Full Text] [Related]
3. Disruption of Ovarian Cancer STAT3 and p38 Signaling with a Small-Molecule Inhibitor of PTP4A3 Phosphatase.
Lazo JS; Isbell KN; Vasa SA; Llaneza DC; Rastelli EJ; Wipf P; Sharlow ER
J Pharmacol Exp Ther; 2023 Mar; 384(3):429-438. PubMed ID: 36627205
[TBL] [Abstract][Full Text] [Related]
4. Credentialing and Pharmacologically Targeting PTP4A3 Phosphatase as a Molecular Target for Ovarian Cancer.
Lazo JS; Sharlow ER; Cornelison R; Hart DJ; Llaneza DC; Mendelson AJ; Rastelli EJ; Tasker NR; Landen CN; Wipf P
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209460
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway.
Rastelli EJ; Sannino S; Hart DJ; Sharlow ER; Lazo JS; Brodsky JL; Wipf P
Bioorg Med Chem Lett; 2021 Aug; 46():128167. PubMed ID: 34089839
[TBL] [Abstract][Full Text] [Related]
6. A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion.
McQueeney KE; Salamoun JM; Ahn JG; Pekic P; Blanco IK; Struckman HL; Sharlow ER; Wipf P; Lazo JS
FASEB J; 2018 Oct; 32(10):5661-5673. PubMed ID: 29746167
[TBL] [Abstract][Full Text] [Related]
7. Targeting ovarian cancer and endothelium with an allosteric PTP4A3 phosphatase inhibitor.
McQueeney KE; Salamoun JM; Burnett JC; Barabutis N; Pekic P; Lewandowski SL; Llaneza DC; Cornelison R; Bai Y; Zhang ZY; Catravas JD; Landen CN; Wipf P; Lazo JS; Sharlow ER
Oncotarget; 2018 Feb; 9(9):8223-8240. PubMed ID: 29492190
[TBL] [Abstract][Full Text] [Related]
8. In-flow photooxygenation of aminothienopyridinones generates iminopyridinedione PTP4A3 phosphatase inhibitors.
Tasker NR; Rastelli EJ; Blanco IK; Burnett JC; Sharlow ER; Lazo JS; Wipf P
Org Biomol Chem; 2019 Feb; 17(9):2448-2466. PubMed ID: 30746541
[TBL] [Abstract][Full Text] [Related]
9. Investigational inhibitors of PTP4A3 phosphatase as antineoplastic agents.
Sharlow ER; Wipf P; McQueeney KE; Bakan A; Lazo JS
Expert Opin Investig Drugs; 2014 May; 23(5):661-73. PubMed ID: 24625356
[TBL] [Abstract][Full Text] [Related]
10. Photooxygenation of an amino-thienopyridone yields a more potent PTP4A3 inhibitor.
Salamoun JM; McQueeney KE; Patil K; Geib SJ; Sharlow ER; Lazo JS; Wipf P
Org Biomol Chem; 2016 Jul; 14(27):6398-402. PubMed ID: 27291491
[TBL] [Abstract][Full Text] [Related]
11. Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival.
den Hollander P; Rawls K; Tsimelzon A; Shepherd J; Mazumdar A; Hill J; Fuqua SA; Chang JC; Osborne CK; Hilsenbeck SG; Mills GB; Brown PH
Cancer Res; 2016 Apr; 76(7):1942-53. PubMed ID: 26921331
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of PTP4A3 in ETV6-RUNX1 acute lymphoblastic leukemia.
Grönroos T; Teppo S; Mehtonen J; Laukkanen S; Liuksiala T; Nykter M; Heinäniemi M; Lohi O
Leuk Res; 2017 Mar; 54():1-6. PubMed ID: 28063378
[TBL] [Abstract][Full Text] [Related]
13. The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia.
Zhou J; Cheong LL; Liu SC; Chong PS; Mahara S; Bi C; Ong KO; Zeng Q; Chng WJ
Mol Cancer; 2012 Sep; 11():72. PubMed ID: 22995644
[TBL] [Abstract][Full Text] [Related]
14. Targeted deletion of the metastasis-associated phosphatase Ptp4a3 (PRL-3) suppresses murine colon cancer.
Zimmerman MW; Homanics GE; Lazo JS
PLoS One; 2013; 8(3):e58300. PubMed ID: 23555575
[TBL] [Abstract][Full Text] [Related]
15. Tapping the therapeutic potential of protein tyrosine phosphatase 4A with small molecule inhibitors.
Tasker NR; Rastelli EJ; Burnett JC; Sharlow ER; Lazo JS; Wipf P
Bioorg Med Chem Lett; 2019 Aug; 29(16):2008-2015. PubMed ID: 31307888
[TBL] [Abstract][Full Text] [Related]
16. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
[TBL] [Abstract][Full Text] [Related]
17. Effect of protein-tyrosine phosphatase 4A3 by small interfering RNA on the proliferation of lung cancer.
Lian YX; Chen R; Xu YH; Peng CL; Hu HC
Gene; 2012 Dec; 511(2):169-76. PubMed ID: 23036709
[TBL] [Abstract][Full Text] [Related]
18. Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility.
Zimmerman MW; McQueeney KE; Isenberg JS; Pitt BR; Wasserloos KA; Homanics GE; Lazo JS
J Biol Chem; 2014 Feb; 289(9):5904-13. PubMed ID: 24403062
[TBL] [Abstract][Full Text] [Related]
19. Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) promotes the aggressiveness of human uveal melanoma through dephosphorylation of CRMP2.
Duciel L; Anezo O; Mandal K; Laurent C; Planque N; Coquelle FM; Gentien D; Manneville JB; Saule S
Sci Rep; 2019 Feb; 9(1):2990. PubMed ID: 30816227
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma.
Mayinuer A; Yasen M; Mogushi K; Obulhasim G; Xieraili M; Aihara A; Tanaka S; Mizushima H; Tanaka H; Arii S
Ann Surg Oncol; 2013 Jan; 20(1):305-17. PubMed ID: 23064776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
